UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
Who is Danny Ocean, the pop star playing at the Nobel Peace Prize ceremony?
The 33-year-old singer collaborated with Nobel Prize winner María Corina Machado during last year's highly-contested elections in Venezuela.
Believe it or not, this book makes taxes fascinating
The Price of Democracy tells the history of taxation from colonization to the present day. It's essential reading for anyone who cares about preserving democracy.
Raul Malo, lead singer of The Mavericks, has died at 60
The son of Cuban immigrants, Malo and his band blended country, rock and roll, folk, jump blues, Latin music and Cajun rhythms into a distinct sound anchored by his unmistakable voice.
Jazz, joy and one ragged Christmas tree: 60 years of ‘A Charlie Brown Christmas’
On Dec. 9, 1965, "A Charlie Brown Christmas" premiered on television. In 1995, Peanuts creator Charles Schulz spoke with NPR's Bob Edwards on Morning Edition.
Ukraine’s last eastern strongholds hang on as Russia fights to take Donbas
Russia is pushing to take over all of eastern Ukraine's Donbas region, where one resident tells NPR that she feels her "life depends on how our guys at the front hold on."
Are we in a recession? Maybe professional Santas can tell us
Demand for professional Santas and other seasonal workers seems to have cooled. Could that be a sign we're in a recession?
